Brief: Synairgen Announces Positive Data From US NIH-LED ACTIV-2 Phase 2 Trial

Synairgen

04/10/2022 07:38

Oct 4 (Reuters) - Synairgen PLC  SYNG.L :
    * DATA FROM THE US NIH-LED ACTIV-2 PHASE 2 TRIAL
    * ANNOUNCES POSITIVE DATA FROM US NIH-LED ACTIV-2 PHASE 2
TRIAL
FOR SNG001 IN HOME-BASED PARTICIPANTS WITH COVID-19

Source text for Eikon:  ID:nRSD6904Ba 
Further company coverage:  SYNG.L 
 ((Reuters.Briefs@thomsonreuters.com;;))